Brigit Biofarmaka Teknologi Tbk. vs Pratama Widya Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Pratama Widya Tbk. trades at Rp1,140 (market cap 996.74B, 42.1K 24h volume). The key difference: Pratama Widya Tbk. is far larger — about 5.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 42.1K). Which is the better fit depends on your goals.
| OBAT | PTPW | |
|---|---|---|
Market Cap | 172.82B | 996.74B |
Volume | 592.2K | 42.1K |
Lot | 5.92K | 421 |
Turnover | 147.05M | 47.44M |
Average Price | 248.31 | 1,126.89 |
Value | 147.05M | 47.44M |
Indicative Equilibrium Price | 254 | 1,140 |
Indicative Equilibrium Volume | 10 | 18 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Pratama Widya Tbk (the Company) was established in the Republic of Indonesia, by deed of notary public Samsul Hadi, S.H., dated 3 June 1981 No. 11, a notary in Jakarta.
Read more on PTPW →